Ultrasound assisted Tru-Cut biopsy of pleural tumors: a prospective analysis of 62 consecutive cases in a high incidence area for malignant mesothelioma Source: Eur Respir J 2002; 20: Suppl. 38, 594s Year: 2002
Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010
The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020
An audit of the use of Abrams‘ pleural biopsy in the diagnosis of mesothelioma Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Usefulness of cytology and blind needle pleural biopsy (BNPB) histopathology findings in malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 50s Year: 2006
Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases Year: 2009
A comparative study of conventional cytology and cell block method in the diagnosis of malignant pleural effusion. Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018
Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience. Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes Year: 2020
A comparative study of conventional cytology and cell block method in the diagnosis of pleural effusion Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
The diagnostic yield of closed pleural biopsies: a 2 year study from Singapore Source: Eur Respir J 2004; 24: Suppl. 48, 248s Year: 2004
Late-breaking abstract: Tumor marker pattern in benign pleural effusion investigation. A case report of increased pleural CA 125 Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011
Survival of patients with malignant pleural effusions: a three-year prospective self-experience study Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Malignant pleural mesothelioma: CT findings in 49 patients Source: Eur Respir J 2002; 20: Suppl. 38, 271s Year: 2002
Retrospective study of transbronchial cryobiopsy (TCB) data in a case series of 20 patients with interstitial lung disease Source: Annual Congress 2012 - The different ways to establish a diagnosis: needle and forcep Year: 2012
A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions Source: Eur Respir J 2013; 41: 18-24 Year: 2013
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis Source: Eur Respir Rev, 30 (162) 210057; 10.1183/16000617.0057-2021 Year: 2021
Malignant pleural mesothelioma: survival-predictive CT elements in 28 patients Source: Eur Respir J 2002; 20: Suppl. 38, 271s Year: 2002
Clinical and histological analysis of malignant mesothelioma - a comprehensive state-wide study Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Malignant pleural mesothelioma (MPM) – 5 years of experience Source: Eur Respir J 2006; 28: Suppl. 50, 91s Year: 2006
A case report: surprising diagnosis of malignant mesothelioma in a patient with malignant pleural effusion, mediastinal lymphoma and intestinal carcinoma in situ Source: Eur Respir J 2004; 24: Suppl. 48, 527s Year: 2004